Insomnia is the most common sleep disorder with huge socio-economic costs. According to the third edition of the International Classification of Sleep Disorders (ICSD-3), it is characterized by difficulty in either initiating sleep, maintaining sleep continuity, or poor sleep quality. However, Chronic Insomnia is more complex, accompanied by daytime impairment of cognition, mood, or performance.

 

The Chronic Insomnia Market report offers a comprehensive analysis of the disease overview, its causes, signs/ symptoms, and diagnosis modalities. The report highlights the available treatment, pipeline therapies, and factors changing the Chronic Insomnia market landscape during the study period 2018-30 in the 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan).

The Chronic Insomnia market size insights report is designed to identify and grab true opportunities in the Chronic Insomnia market landscape, help clients form collaborations and ink deals that give them a competitive advantage and plan strategic moves to yield maximum returns.

 

Some key facts of the Chronic Insomnia market report: 

• The total diagnosed Chronic Insomnia prevalent population in the 7MM countries was estimated to be 5,585,128 cases in 2020.
• The US reported the highest Chronic Insomnia patient pool, more than 2,500,000 in 2020.
• The US accounted for the maximum share of the Chronic Insomnia market size, approximately 66.42% of the overall market size of Chronic Insomnia in 2020.
• Key pharmaceutical companies energetically working in the Chronic Insomnia market are Idorsia Pharmaceuticals, Janssen Research & Development/Minerva Neurosciences, and Sequential Medicine, among others.
• Key pipeline therapies set to place their foot in the market during the forecast period 2021-30 include Daridorexant, Seltorexant, SM-1, and several others.

 

 

 

Interested in learning more? Request for Sample @ Chronic Insomnia Market Analysis and Forecast

 

Various studies worldwide have shown the prevalence of insomnia in 10–30% of the population, some even as high as 50–60%. As per DelveInsight’s Chronic Insomnia epidemiological analysis, Chronic Insomnia is slightly more prevalent among females than males.

 

The Chronic Insomnia market report offers historical and forecasted epidemiological analysis during the study period 2018-30 in the 7MM segmented into:

• Chronic Insomnia Prevalent Cases
• Chronic Insomnia Diagnosed Prevalent Cases
• Gender-specific Chronic Insomnia Cases
• Age-specific Chronic Insomnia Cases

 

For more insights, visit Chronic Insomnia Epidemiological Analysis and Forecast

 

Chronic Insomnia Market

The primary goal of the Chronic Insomnia market is to improve sleeping habits and alleviate symptoms such as distress and dysfunction. It can be managed with the help of psychological therapy, pharmacologic therapy, or a combination of both.

Psychological therapy options present in the Chronic Insomnia market include cognitive behavioral therapy for insomnia (CBT-I), multicomponent behavioral therapy or brief behavioral therapy (BBT) for insomnia, and other interventions, such as stimulus control, relaxation strategies, and sleep restriction.

Benzodiazepines are frequently prescribed to treat insomnia. Five benzodiazepines (estazolam, flurazepam, quazepam, temazepam, and triazolam) are in market as the FDA-approved medications for insomnia management. Non-benzodiazepine hypnotics include zopiclone, zolpidem, and zaleplon. Orexin receptor antagonists, including Dayvigo and Belsomra, recently gained popularity in the Chronic Insomnia market therapy.

 

 

Chronic Insomnia Pipeline Therapies

• Daridorexant: Idorsia Pharmaceuticals
• Seltorexant: Janssen Pharmaceuticals
• SM-1: Sequential Medicine
• And Many More

 

Scope of the Report 

Coverage: 7MM (the US, EU5, and Japan)

Study Period: 2018-30

Key Companies: Idorsia Pharmaceuticals, Janssen Pharmaceuticals, Sequential Medicine

Key Chronic Insomnia Pipeline Therapies: Daridorexant, Seltorexant, SM-1

Chronic Insomnia Market Segmentation: By Geography, By Chronic Insomnia Therapies

Analysis: Comparative and conjoint analysis of Chronic Insomnia emerging therapies

Tools used: SWOT analysis, Conjoint Analysis, Porter’s Five Forces, PESTLE analysis, BCG Matrix analysis methods.

Case Studies

KOL’s Views

Analyst’s Views

 

Table of Contents

1	Key Insights
2	Report Introduction
3	Chronic Insomnia Market Overview at a Glance
4	Executive Summary of Chronic Insomnia
5	Chronic Insomnia Epidemiology and Patient Population
6	Chronic Insomnia Patient Journey
7	Organizations contributing to Chronic Insomnia
8	Treatment Algorithm, Current Treatment, and Medical Practices
9	Key Endpoints in Chronic Insomnia Clinical Trials
10	Chronic Insomnia Marketed Therapies
11	Chronic Insomnia Emerging Therapies
12	Other Chronic Insomnia Promising Therapies
13	Chronic Insomnia: 7 Major Market Analysis
14	Access and Reimbursement Overview of Chronic Insomnia
15	KOL Reviews
16	Case Reports
17	Chronic Insomnia Market Drivers
18	Chronic Insomnia Market Barriers
19	Chronic Insomnia Market Access
20	SWOT Analysis
21	Disclaimer
22	DelveInsight Capabilities
23	About DelveInsight

DelveInsght’s Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.

 

About Delveinsight: 

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Know more about our competitive intelligence services.

Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/chronic-insomnia-market